Novartis (NVS) Tops Q2 EPS by 13c; offers outlook

Novartis (NYSE: NVS) reported Q2 EPS of $1.97, $0.13 better than the analyst estimate of $1.84. Revenue for the quarter came in at $12.51 billion versus the consensus estimate of $12.35 billion.

2024 OUTLOOK

Net sales Expected to grow high single to low double-digit (unchanged).
Core operating income Expected to grow mid- to high teens (from low double-digit to mid-teens)

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• TechCreate Group faces NYSE American delisting proceedings